The BMP type II receptor is located in lipid rafts, including caveolae, of pulmonary endothelium in vivo and in vitro

Vascular Pharmacology

Volumn 44, Issue 1, 2006, Pages 50-59

  Ramos, M ^a   Lame M W ^a   Segall, H J ^a   Wilson, D W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bone morphogenetic protein type II receptor; Caveolae; Pulmonary hypertension

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTOR; CAVEOLIN 1;

ADULT; ANIMAL CELL; APICAL MEMBRANE; ARTERY ENDOTHELIUM; ARTICLE; BASEMENT MEMBRANE; CAVEOLA; CELL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; ELECTRON MICROSCOPY; FLUORESCENCE HISTOCHEMISTRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; LIPID RAFT; LUNG ALVEOLUS EPITHELIUM; LUNG BLOOD VESSEL; MOUSE; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT;

ADULT; ANIMALS; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; CAVEOLAE; CAVEOLIN 1; CELL LINE; CHILD, PRESCHOOL; ENDOTHELIUM, VASCULAR; FEMALE; GOLGI APPARATUS; HUMANS; LUNG; MALE; MEMBRANE MICRODOMAINS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 29144475243     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2005.09.007     Document Type: Article

References (55)

1. P. Abedinpour, and B. Jergil Isolation of a caveolae-enriched fraction from rat lung by affinity partitioning and sucrose gradient centrifugation Anal. Biochem. 313 2003 1 8
2. T. Akiyoshi, K. Uchida, and S. Tateyama Expression of bone morphogenetic protein-6 and bone morphogenetic protein receptors in myoepithelial cells of canine mammary gland tumors Vet. Pathol. 41 2004 154 163
3. R.G. Anderson The caveolae membrane system Annu. Rev. Biochem. 67 1998 199 225
4. R.G. Anderson, and K. Jacobson A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains Science 296 2002 1821 1825
5. C. Atkinson, S. Stewart, P.D. Upton, R. Machado, J.R. Thomson, R.C. Trembath, and N.W. Morrell Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor Circulation 105 2002 1672 1678
6. H. Beppu, O. Minowa, K. Miyazono, and M. Kawabata cDNA cloning and genomic organization of the mouse BMP type II receptor Biochem. Biophys. Res. Commun. 235 1997 499 504
7. M. Bucci, J.P. Gratton, R.D. Rudic, L. Acevedo, F. Roviezzo, G. Cirino, and W.C. Sessa In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation Nat. Med. 6 2000 1362 1367
8. L.K. Chaney, and B.S. Jacobson Coating cells with colloidal silica for high yield isolation of plasma membrane sheets and identification of transmembrane proteins J. Biol. Chem. 258 1983 10062 10072
9. M. Czarny, Y. Lavie, G. Fiucci, and M. Liscovitch Localization of phospholipase D in detergent-insoluble, caveolin-rich membrane domains. Modulation by caveolin-1 expression and caveolin-182-101 J. Biol. Chem. 274 1999 2717 2724
10. M. de Caestecker The transforming growth factor-beta superfamily of receptors Cytokine Growth Factor Rev. 15 2004 1 11
11. Z. Deng, J.H. Morse, S.L. Slager, N. Cuervo, K.J. Moore, G. Venetos, S. Kalachikov, E. Cayanis, S.G. Fischer, R.J. Barst, S.E. Hodge, and J.A. Knowles Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene Am. J. Hum. Genet. 67 2000 737 744
12. R. Derynck, and Y.E. Zhang Smad-dependent and Smad-independent pathways in TGF-beta family signalling Nature 425 2003 577 584
13. C.J. Fielding Caveolae and signaling Curr. Opin. Lipidol. 12 2001 281 287
14. M.W. Geraci, M. Moore, T. Gesell, M.E. Yeager, L. Alger, H. Golpon, B. Gao, J.E. Loyd, R.M. Tuder, and N.F. Voelkel Gene expression patterns in the lungs of patients with primary pulmonary hypertension: a gene microarray analysis Circ. Res. 88 2001 555 562
15. L. Gilboa, R.G. Wells, H.F. Lodish, and Y.I. Henis Oligomeric structure of type I and type II transforming growth factor beta receptors: homodimers form in the ER and persist at the plasma membrane J. Cell Biol. 140 1998 767 777
16. W.J. Gullick, J. Downward, and M.D. Waterfield Antibodies to the autophosphorylation sites of the epidermal growth factor receptor protein-tyrosine kinase as probes of structure and function Embo. J. 4 1985 2869 2877
17. J.C. Hardwick, G.R. Van Den Brink, S.A. Bleuming, I. Ballester, J.M. Van Den Brande, J.J. Keller, G.J. Offerhaus, S.J. Van Deventer, and M.P. Peppelenbosch Bone morphogenetic protein 2 is expressed by, and acts upon, mature epithelial cells in the colon Gastroenterology 126 2004 111 121
18. B.S. Jacobson, J.E. Schnitzer, M. McCaffery, and G.E. Palade Isolation and partial characterization of the luminal plasmalemma of microvascular endothelium from rat lungs Eur. J. Cell Biol. 58 1992 296 306
19. L.C. Javois Immunocytochemical Methods and Protocols. Methods in Molecular Biology 1994 Humana Press Inc. Totowa
20. M. Kawabata, A. Chytil, and H.L. Moses Cloning of a novel type II serine/threonine kinase receptor through interaction with the type I transforming growth factor-beta receptor J. Biol. Chem. 270 1995 5625 5630
21. T.V. Kurzchalia, and R.G. Parton Membrane microdomains and caveolae Curr. Opin. Cell. Biol. 11 1999 424 431
22. E.M. Langenfeld, and J. Langenfeld Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors Mol. Cancer Res. 2 2004 141 149
23. F. Liu, F. Ventura, J. Doody, and J. Massague Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs Mol. Cell Biol. 15 1995 3479 3486
24. J. Liu, B. Razani, S. Tang, B.I. Terman, J.A. Ware, and M.P. Lisanti Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells. Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1 J. Biol. Chem. 274 1999 15781 15785
25. R.D. Machado, M.W. Pauciulo, J.R. Thomson, K.B. Lane, N.V. Morgan, L. Wheeler, J.A. Phillips III, J. Newman, D. Williams, N. Galie, A. Manes, K. McNeil, M. Yacoub, G. Mikhail, P. Rogers, P. Corris, M. Humbert, D. Donnai, G. Martensson, L. Tranebjaerg, J.E. Loyd, R.C. Trembath, and W.C. Nichols BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension Am. J. Hum. Genet. 68 2001 92 102
26. J. Massague, and B. Kelly Internalization of transforming growth factor-beta and its receptor in BALB/c 3T3 fibroblasts J. Cell. Physiol. 128 1986 216 222
27. I. Mellman Endocytosis and molecular sorting Annu. Rev. Cell Dev. Biol. 12 1996 575 625
28. C. Mineo, G.N. Gill, and R.G. Anderson Regulated migration of epidermal growth factor receptor from caveolae J. Biol. Chem. 274 1999 30636 30643
29. C. Mineo, G.L. James, E.J. Smart, and R.G. Anderson Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membrane J. Biol. Chem. 271 1996 11930 11935
30. R.D. Minshall, W.C. Sessa, R.V. Stan, R.G. Anderson, and A.B. Malik Caveolin regulation of endothelial function Am. J. Physiol., Lung Cell. Mol. Physiol. 285 2003 L1179 L1183
31. I.R. Nabi, and P.U. Le Caveolae/raft-dependent endocytosis J. Cell. Biol. 161 2003 673 677
32. J.H. Newman, L. Wheeler, K.B. Lane, E. Loyd, R. Gaddipati, J.A. Phillips III, and J.E. Loyd Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred N. Engl. J. Med. 345 2001 319 324
33. A. Nohe, S. Hassel, M. Ehrlich, F. Neubauer, W. Sebald, Y.I. Henis, and P. Knaus The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways J. Biol. Chem. 277 2002 5330 5338
34. A. Nohe, E. Keating, P. Knaus, and N.O. Petersen Signal transduction of bone morphogenetic protein receptors Cell. Signal. 16 2004 291 299
35. T. Nohno, T. Ishikawa, T. Saito, K. Hosokawa, S. Noji, D.H. Wolsing, and J.S. Rosenbaum Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors J. Biol. Chem. 270 1995 22522 22526
36. P. Oh, and J.E. Schnitzer Cell Biology: A Laboratory Handbook 1998 34 44 Celis, J.E.
37. T. Okamoto, A. Schlegel, P.E. Scherer, and M.P. Lisanti Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane J. Biol. Chem. 273 1998 5419 5422
38. L. Parker, D.G. Stathakis, and K. Arora Regulation of BMP and activin signaling in Drosophila Prog. Mol. Subcell. Biol. 34 2004 73 101
39. G.A. Rabinovich, R.E. Ramhorst, N. Rubinstein, A. Corigliano, M.C. Daroqui, E.B. Kier-Joffe, and L. Fainboim Induction of allogenic T-cell hyporesponsiveness by galectin-1-mediated apoptotic and non-apoptotic mechanisms Cell Death Differ. 9 2002 661 670
40. B. Razani, J.A. Engelman, X.B. Wang, W. Schubert, X.L. Zhang, C.B. Marks, F. Macaluso, R.G. Russell, M. Li, R.G. Pestell, D. Di Vizio, H. Hou Jr., B. Kneitz, G. Lagaud, G.J. Christ, W. Edelmann, and M.P. Lisanti Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities J. Biol. Chem. 276 2001 38121 38138
41. B. Razani, X.L. Zhang, M. Bitzer, G. von Gersdorff, E.P. Bottinger, and M.P. Lisanti Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor J. Biol. Chem. 276 2001 6727 6738
42. C. Regazzoni, K.H. Winterhalter, and L. Rohrer Type I collagen induces expression of bone morphogenetic protein receptor type II Biochem. Biophys. Res. Commun. 283 2001 316 322
43. F. Rodriguez-Pascual, M. Redondo-Horcajo, and S. Lamas Functional cooperation between Smad proteins and activator protein-1 regulates transforming growth factor-beta-mediated induction of endothelin-1 expression Circ. Res. 92 2003 1288 1295
44. A. Rosendahl, E. Pardali, M. Speletas, P. Ten Dijke, C.H. Heldin, and P. Sideras Activation of bone morphogenetic protein/Smad signaling in bronchial epithelial cells during airway inflammation Am. J. Respir. Cell. Mol. Biol. 27 2002 160 169
45. B.L. Rosenzweig, T. Imamura, T. Okadome, G.N. Cox, H. Yamashita, P. ten Dijke, C.H. Heldin, and K. Miyazono Cloning and characterization of a human type II receptor for bone morphogenetic proteins Proc. Natl. Acad. Sci. U. S. A. 92 1995 7632 7636
46. N. Rudarakanchana, J.A. Flanagan, H. Chen, P.D. Upton, R. Machado, D. Patel, R.C. Trembath, and N.W. Morrell Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension Hum. Mol. Genet. 11 2002 1517 1525
47. A. Schlegel, and M.P. Lisanti The caveolin triad: caveolae biogenesis, cholesterol trafficking, and signal transduction Cytokine Growth Factor Rev. 12 2001 41 51
48. E.J. Smart, Y.S. Ying, C. Mineo, and R.G. Anderson A detergent-free method for purifying caveolae membrane from tissue culture cells Proc. Natl. Acad. Sci. U. S. A. 92 1995 10104 10108
49. K.S. Song, S. Li, T. Okamoto, L.A. Quilliam, M. Sargiacomo, and M.P. Lisanti Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains J. Biol. Chem. 271 1996 9690 9697
50. R.V. Stan Structure and function of endothelial caveolae Microsc. Res. Tech. 57 2002 350 364
51. J.H. Venable, and R. Coggeshall A simplified lead citrate stain for use in electron microscopy J. Cell. Biol. 25 1965 407 408
52. R.G. Wells, H. Yankelev, H.Y. Lin, and H.F. Lodish Biosynthesis of the type I and type II TGF-beta receptors. Implications for complex formation J. Biol. Chem. 272 1997 11444 11451
53. K. Yamaoka, A. Ingendoh, S. Tsubuki, Y. Nagai, and Y. Sanai Structural and functional characterization of a novel tumor-derived rat galectin-1 having transforming growth factor (TGF) activity: the relationship between intramolecular disulfide bridges and TGF activity J. Biochem. (Tokyo) 119 1996 878 886
54. X. Yang, L. Long, M. Southwood, N. Rudarakanchana, P.D. Upton, T. Jeffery, C. Atkinson, H. Chen, R.C. Trembath, and N.W. Morrell Dysfunctional smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension Circ. Res. 96 10 2005 1053 1063
55. Y.Y. Zhao, Y. Liu, R.V. Stan, L. Fan, Y. Gu, N. Dalton, P.H. Chu, K. Peterson, J. Ross Jr., and K.R. Chien Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice Proc. Natl. Acad. Sci. U. S. A. 99 2002 11375 11380